Cancer Screening: The Journey from Epidemiology to Policy

Department of Thoracic Surgery, Vanderbilt University, Nashville, TN, USA.
Annals of epidemiology (Impact Factor: 2). 06/2012; 22(6):439-45. DOI: 10.1016/j.annepidem.2012.03.004
Source: PubMed


Cancer screening procedures have brought great benefit to the public's health. However, the science of cancer screening and the evidence arising from research in this field as it is applied to policy is complex and has been difficult to communicate, especially on the national stage. We explore how epidemiologists have contributed to this evidence base and to its translation into policy.
Our essay focuses on breast and lung cancer screening to identify commonalities of experience by epidemiologists across two different cancer sites and describe how epidemiologists interact with evolving scientific and policy environments.
We describe the roles and challenges that epidemiologists encounter according to the maturity of the data, stakeholders, and the related political context. We also explore the unique position of cancer screening as influenced by the legislative landscape where, due to recent healthcare reform, cancer screening research plays directly into national policy.
In the complex landscape for cancer screening policy, epidemiologists can increase their impact by learning from past experiences, being well prepared and communicating effectively.

3 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cancer epidemiology is at the cusp of a paradigm shift-propelled by an urgent need to accelerate the pace of translating scientific discoveries into health care and population health benefits. As part of a strategic planning process for cancer epidemiologic research, the Epidemiology and Genomics Research Program (EGRP) at the National Cancer Institute (NCI) is leading a "longitudinal" meeting with members of the research community to engage in an on-going dialogue to help shape and invigorate the field. Here, we review a translational framework influenced by "drivers" that we believe have begun guiding cancer epidemiology toward translation in the past few years and are most likely to drive the field further in the next decade. The drivers include: (i) collaboration and team science, (ii) technology, (iii) multilevel analyses and interventions, and (iv) knowledge integration from basic, clinical, and population sciences. Using the global prevention of cervical cancer as an example of a public health endeavor to anchor the conversation, we discuss how these drivers can guide epidemiology from discovery to population health impact, along the translational research continuum. Cancer Epidemiol Biomarkers Prev; 1-8. ©2013 AACR.
    Cancer Epidemiology Biomarkers & Prevention 01/2013; 22(2). DOI:10.1158/1055-9965.EPI-12-1262 · 4.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Research suggests that cancer screening messages are more persuasive when framed in terms of the costs of not obtaining screening (i.e., loss-framed) than when framed in terms of the benefits of obtaining screening (i.e., gain-framed). However, to what extent these findings have been integrated into public health practice is unknown. To analyze message framing of cancer screening information, the present study examined message framing of cancer screening announcement articles that appeared in municipal newsletters published from 23 wards in central Tokyo, Japan. Two independent raters coded the articles. Gain- and loss-framed sentences in each article were identified, and based on what the sentences conveyed, articles were classified into gain-framed, loss-framed, mixed-framed, and non-framed.Result: Inter-rater reliability was acceptable (intraclass correlation coefficient = 0.88). Of the 129 articles evaluated, the total number of gain-framed sentences was 87, while that of loss-framed sentences was six. The total number of gain-framed articles was 32 (24.8%) while that of loss-framed articles was zero (0%). Five (3.9%) articles were mixed-framed. Ninety-two (71.3%) articles were non-framed. Cancer screening announcement articles of municipal newsletters were mostly non-framed or gain-framed in 23 Tokyo wards in Japan. The absence of loss-framed articles and only a small number of loss-framed messages indicate a missed opportunity to persuade readers to obtain cancer screenings. Loss-framed messages and articles need to be increased to enhance the persuasiveness of cancer screening information in municipal newsletters.
    BMC Research Notes 12/2014; 7(1):896. DOI:10.1186/1756-0500-7-896
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Cancer is a multifactorial disease characterized by the uncontrolled and disperse growth of abnormal cells. If this growth and its dispersion are not controlled at the appropriate time, it could result in metastasis, which increases the risk of death associated to this disease. In the last years, the oxidative stress had become a therapeutic target against this disease, due to its important role in the carcinogenesis process that has been evidenced and of there that the antioxidants and pro-oxidants are potential antitumor agents that could be administered alone or as co-adjuvants in the chemotherapies and radiotherapies. Objective: To review the implication of oxidative stress in the DNA damages and in the carcinogenesis process. Methods: Thematic review. An informatic search was carried out in English and Spanish, in the databases ScienceDirect and Scielo between the years 2009 and 2013. Studies in humans and animals were included. 150 summaries were obtained, 50 summaries were considered as pertinent, and of transcendence and contribution. All were acquired in full text, reviewed and cited lengthways of the present thematic review. Results: The oxidative stress occurs as an imbalance between the production of reactive species and the antioxidant system that neutralizes them. The reactive species had been implied in the carcinogenesis process and due to they could mediate the activation of cellular proliferation ways and to inhibit the apoptosis, also it has been demonstrated that the oxidative damage to the DNA carries to mutations favoring this process. Conclusions: The oxidative stress could be an important cellular event implied in the carcinogenesis, therefore the use of antioxidant and pro-oxidant agents as potent antitumor agents constitutes an alternative for the anticancer therapy, already be alone or as co-adjuvant. Although, more studies are required to allow validating the obtained results. Rev.cienc.biomed. 2015;6(1):107-117 KEYWORDS Cancer; Oxidative stress; Antioxidants.